Eva Live Inc SEC Filings

EVA Live Inc. announced a non-binding Letter of Intent for a strategic partnership with Dermatech Mobile Care, doing business as Spiro Senior Care. EVA Live plans to obtain a 25% equity ownership position in the Spiro Senior venture.

Under the proposed agreement, EVA Live would invest up to $20 million in cash, assets, and resources to help expand the Spiro platform, deploy AI-driven technology, and support nationwide senior-care growth initiatives. The collaboration, alongside senior-housing operator Meridian Senior Living, aims to apply EVA’s artificial intelligence and digital medical infrastructure to improve care coordination and resident outcomes in the rapidly expanding senior healthcare market.

Eva Live Inc. reports Q1 2026 results showing rapid growth in its balance sheet but a sharp swing into loss. Revenue was $3,903,231, while net loss reached $8,564,076, compared with a profit a year earlier. General and administrative expenses jumped to $9,279,934, driven largely by $7,799,169 of stock-based compensation, including a major CEO option award.

Cash rose to $5,769,269 and working capital to $17,657,580, aided by a new $7,560,000 senior secured convertible note from Streeterville Capital that created a $4,923,000 derivative liability. Media traffic purchases consumed about 95% of revenue, materially compressing margins. Management identifies substantial doubt about going concern but relies on an executed $100,000,000 at-the-market equity program and expected receivables collections to alleviate that doubt.

Eva Live Inc. announced the launch of “Eva Brain,” a fully autonomous AI marketing agent designed to manage and optimize digital advertising campaigns without traditional human campaign teams. The system can handle campaign creation, bid and budget optimization, audience targeting, creative generation, fraud detection, and continuous learning across platforms such as Google Ads, Meta, TikTok, Taboola, and Outbrain.

The company positions Eva Brain as a new category of autonomous marketing agents, built on its proprietary “Eva Brain stack” using large-scale data ingestion, reinforcement learning, and predictive modeling. For the year ended December 31, 2025, Eva Live reported revenue of $17,037,328, representing 82.6% year-over-year growth, and net income of $8,127,313 compared to a net loss of $(3,753,268) in 2024, alongside expansion to 20 active enterprise clients from 15 a year earlier.

Eva Live Inc. entered into an Equity Distribution Agreement with Maxim Group LLC that allows the company to sell shares of common stock with an aggregate offering price of up to $100,000,000 in an at-the-market program.

Maxim will act as sales agent, using commercially reasonable efforts to place shares, and will receive a 3.0% commission on gross proceeds, plus specified expense reimbursements. Eva Live is not required to sell any shares and the agreement can be terminated by either party on five days’ notice or upon earlier specified events. The shares are registered under an effective Form S-3 shelf registration, and net proceeds are intended for working capital and general corporate purposes.

Eva Live Inc. has filed a prospectus supplement to sell up to $100,000,000 of its common stock in an at-the-market offering through Maxim Group LLC as sales agent. The plan permits sales from time to time under an Equity Distribution Agreement; Maxim will receive a 3% commission on gross proceeds.

The cover math shows 31,342,285 shares outstanding prior to this offering and, assuming sale of 25,125,628 shares at $3.98 per share, pro forma as adjusted outstanding would be up to 58,748,713 shares. The company discloses that CEO David Boulette beneficially owns approximately 63.02% of common stock. Financials show a pro forma as adjusted cash balance and capitalization reflecting the assumed proceeds; the filing also discloses a going concern qualification in prior filings.

Eva Live Inc. is registering up to 8,381,375 shares of Common Stock issuable upon conversion of a secured convertible note (the Initial Note) issued under a Purchase Agreement with Streeterville Capital, LLC. The registration covers shares convertible into common stock at the Conversion Price; the Company will not receive additional cash proceeds upon conversion. Shares outstanding were 31,342,285 as of December 31, 2025, and outstanding shares following full conversion would be up to 39,723,660 assuming conversion of the Initial Note. The Initial Note had an original principal amount of $7,560,000 and was issued for gross proceeds of $7,000,000. Conversion mechanics and the conversion price are described in the Initial Note and this prospectus supplement.

Eva Live Inc. reports a financing transaction involving a securities purchase agreement with Streeterville Capital, LLC for a secured convertible note with an aggregate original principal amount of $7,560,000. The note is convertible into Eva Live common stock.

The shares of common stock underlying this note were registered under the company’s shelf registration statement on Form S-3, which was declared effective by the SEC on March 24, 2026, and are covered by a related prospectus supplement filed on March 30, 2026.

Eva Live Inc. files a shelf registration to offer up to $250,000,000 of securities from time to time, including common stock, preferred stock, depositary shares, warrants, rights and units.

The registration permits multiple offerings under a single prospectus with specific terms to be provided in prospectus supplements and contemplates sales directly, through agents, underwriters or dealers. The prospectus notes the company is an emerging growth company, lists 31,485,389 shares of common stock issued and outstanding as of March 17, 2026, and discloses going concern language in its audited financial statements.